Mrs. Debra Lynn Glass, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3500 Old Washington Rd, Suite302, Waldorf, MD 20602 Phone: 301-645-8867 Fax: 301-645-2330 |
News Archive
DelMar Pharmaceuticals, Inc. today announced additional positive interim data from an ongoing Phase I/II clinical trial of VAL-083 in patients with recurrent glioblastoma multiforme (GBM) or progressive secondary brain tumor.
A concerted effort to standardize delirium assessment and treatment helped a west Texas hospital reduce the use of high-risk medications and improve the quality of care for critically ill patients, according to a study published in Critical Care Nurse.
A group of UK academics are calling for targets for mental health in order to meet the healthcare challenges of the next decade.
New long term data showed that Vimpat- (lacosamide) C-V provided sustained reduction in seizure frequency for up to five years when used as an add-on treatment for uncontrolled partial onset seizures in adults with epilepsy. In addition post-hoc exploratory analyses showed that adjunctive lacosamide treatment reduced partial-onset seizure frequency and improved responder rates when added to a broad range of antiepileptic drugs (AEDs) including both traditional sodium channel-blocking agents and those that act on non-sodium channel-targets.
› Verified 6 days ago